Filter posts

Need for Patent Reform May be Overblown

Amid the cacophony of calls for patent reform legislation, mounting evidence demonstrates patent trolling may …

BIO Submits Joint Supplemental Comments on the USPTO March Guidance

Last week BIO, alongside a number of member companies and private individuals, submitted supplemental comments …

Patent Cases Down by 40% in 2014

The number of new patent cases filed in federal court has dropped by an astonishing …

Should the USPTO Allow the Patenting of Living Organisms?

Last year, a question was submitted to the GMO advocacy website GMOAnswers about whether or …

Detailed Report Examines the Crucial Role of Patents in Genetic Testing

In The Critical Role of Patents in the Development, Commercialization, and Utilization of Innovative Genetic …

BIO Submits Amicus Briefs in Braintree v. Novel, Gilead v. Natco, and Bristol-Myers Squibb v. Teva P...

BIO has submitted briefs in three recent cases which could significantly impair drug and biotechnology …

PTO Patent Examinations in the wake of Mayo and Myriad

Biotech patent applicants are finding themselves in uncharted waters.   After the Supreme Court’s decisions …

BIO Submits Comments on “Myriad” PTO Patent Guidance

On July 31st, BIO, alongside a group of international bioindustry trade associations submitted comments to …

Protecting your IP Overseas

According to the World Intellectual Property Organization (WIPO), nearly 100,000 biotechnology and pharmaceutical patent applications …

Patent Parameters

Supreme Court Finds Naturally Occurring DNA to Be Patent Ineligible Last summer, the Supreme Court …